FRASER & COMPANY | MONO PHARMACARE LTD. | FRASER & COMPANY/ MONO PHARMACARE LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -17.1 | - | - | View Chart |
P/BV | x | 0.5 | 5.7 | 9.1% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
FRASER & COMPANY MONO PHARMACARE LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
FRASER & COMPANY Mar-23 |
MONO PHARMACARE LTD. Mar-23 |
FRASER & COMPANY/ MONO PHARMACARE LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 11 | NA | - | |
Low | Rs | 6 | NA | - | |
Sales per share (Unadj.) | Rs | 12.9 | 26.7 | 48.4% | |
Earnings per share (Unadj.) | Rs | 0.4 | 0.8 | 55.1% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 0.8 | 70.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 9.8 | 11.1 | 89.0% | |
Shares outstanding (eoy) | m | 8.12 | 12.37 | 65.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0 | - | |
Avg P/E ratio | x | 19.3 | 0 | - | |
P/CF ratio (eoy) | x | 14.3 | 0 | - | |
Price / Book Value ratio | x | 0.8 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 66 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 8 | 25.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 105 | 331 | 31.8% | |
Other income | Rs m | 0 | 1 | 3.3% | |
Total revenues | Rs m | 105 | 331 | 31.7% | |
Gross profit | Rs m | 7 | 22 | 29.4% | |
Depreciation | Rs m | 1 | 1 | 235.3% | |
Interest | Rs m | 1 | 9 | 8.3% | |
Profit before tax | Rs m | 5 | 13 | 35.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 4 | 32.7% | |
Profit after tax | Rs m | 3 | 9 | 36.2% | |
Gross profit margin | % | 6.3 | 6.8 | 92.7% | |
Effective tax rate | % | 26.3 | 28.3 | 93.1% | |
Net profit margin | % | 3.3 | 2.9 | 114.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 114 | 611 | 18.6% | |
Current liabilities | Rs m | 41 | 336 | 12.1% | |
Net working cap to sales | % | 69.5 | 83.3 | 83.5% | |
Current ratio | x | 2.8 | 1.8 | 153.4% | |
Inventory Days | Days | 64 | 6 | 989.7% | |
Debtors Days | Days | 366,539,249 | 2,413 | 15,192,397.0% | |
Net fixed assets | Rs m | 21 | 14 | 151.0% | |
Share capital | Rs m | 81 | 124 | 65.6% | |
"Free" reserves | Rs m | -1 | 13 | -9.3% | |
Net worth | Rs m | 80 | 137 | 58.4% | |
Long term debt | Rs m | 3 | 153 | 2.0% | |
Total assets | Rs m | 135 | 625 | 21.6% | |
Interest coverage | x | 7.0 | 2.4 | 291.4% | |
Debt to equity ratio | x | 0 | 1.1 | 3.4% | |
Sales to assets ratio | x | 0.8 | 0.5 | 146.9% | |
Return on assets | % | 3.1 | 3.0 | 103.3% | |
Return on equity | % | 4.3 | 6.9 | 61.9% | |
Return on capital | % | 6.5 | 7.8 | 84.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2 | -395 | -0.6% | |
From Investments | Rs m | -7 | -12 | 61.0% | |
From Financial Activity | Rs m | NA | 407 | 0.0% | |
Net Cashflow | Rs m | -5 | 0 | -1,302.8% |
Indian Promoters | % | 3.1 | 56.7 | 5.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 96.9 | 43.3 | 223.8% | |
Shareholders | 6,193 | 418 | 1,481.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare FRASER & COMPANY With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | FRASER & COMPANY | MONO PHARMACARE LTD. |
---|---|---|
1-Day | 1.19% | 0.00% |
1-Month | 4.49% | -7.40% |
1-Year | -3.76% | 39.12% |
3-Year CAGR | -3.23% | 11.63% |
5-Year CAGR | -10.73% | 6.83% |
* Compound Annual Growth Rate
Here are more details on the FRASER & COMPANY share price and the MONO PHARMACARE LTD. share price.
Moving on to shareholding structures...
The promoters of FRASER & COMPANY hold a 3.1% stake in the company. In case of MONO PHARMACARE LTD. the stake stands at 56.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FRASER & COMPANY and the shareholding pattern of MONO PHARMACARE LTD..
Finally, a word on dividends...
In the most recent financial year, FRASER & COMPANY paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
MONO PHARMACARE LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of FRASER & COMPANY, and the dividend history of MONO PHARMACARE LTD..
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.